- Home
- AUID vs ARTV Comparison
AUID vs ARTV Comparison
Compare AUID & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUID
- ARTV
- Stock Information
- Founded
- AUID 2009
- ARTV 2019
- Country
- AUID United States
- ARTV United States
- Employees
- AUID N/A
- ARTV N/A
- Industry
- AUID Computer Software: Prepackaged Software
- ARTV
- Sector
- AUID Technology
- ARTV
- Exchange
- AUID Nasdaq
- ARTV NYSE
- Market Cap
- AUID 72.6M
- ARTV 61.9M
- IPO Year
- AUID N/A
- ARTV 2024
- Fundamental
- Price
- AUID $4.40
- ARTV $1.98
- Analyst Decision
- AUID
- ARTV Strong Buy
- Analyst Count
- AUID 0
- ARTV 8
- Target Price
- AUID N/A
- ARTV $18.14
- AVG Volume (30 Days)
- AUID 107.4K
- ARTV 118.2K
- Earning Date
- AUID 08-07-2025
- ARTV 05-08-2025
- Dividend Yield
- AUID N/A
- ARTV N/A
- EPS Growth
- AUID N/A
- ARTV N/A
- EPS
- AUID N/A
- ARTV N/A
- Revenue
- AUID $1,025,363.00
- ARTV N/A
- Revenue This Year
- AUID N/A
- ARTV N/A
- Revenue Next Year
- AUID N/A
- ARTV N/A
- P/E Ratio
- AUID N/A
- ARTV N/A
- Revenue Growth
- AUID 230.96
- ARTV N/A
- 52 Week Low
- AUID $4.01
- ARTV $1.78
- 52 Week High
- AUID $12.31
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- AUID 34.88
- ARTV N/A
- Support Level
- AUID $5.02
- ARTV N/A
- Resistance Level
- AUID $5.47
- ARTV N/A
- Average True Range (ATR)
- AUID 0.47
- ARTV 0.00
- MACD
- AUID -0.02
- ARTV 0.00
- Stochastic Oscillator
- AUID 16.67
- ARTV 0.00
About AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).